查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613235

客自订抗体市场：按类型、按服务、按来源、按研究领域、按最终用户、按应用 - 2025-2030 年全球预测

Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

客自订抗体市场2023年估值为7.5586亿美元，预计到2024年将达到8.7188亿美元，复合年增长率为16.10%，到2030年将达到21.499亿美元。

自订抗体市场的定义是开发和销售针对特定抗原或表位定制的抗体，用于研究、诊断和治疗的多种应用。对客自订抗体的需求源于其提供目标蛋白质特异性和检测灵敏度的能力，这在免疫学、肿瘤学和神经生物学等领域非常重要。研究应用包括 ELISA、西方印渍术、免疫组织化学和流式细胞技术，并用于製药公司、学术研究机构和诊断实验室等最终使用领域。推动市场开拓的主要因素是慢性病盛行率的上升、研发投入的增加以及生物技术公司与研究机构之间合作的加强。该市场的最新机会包括噬菌体展示和次世代定序，这些技术提高了快速开发高亲和性抗体的能力。市场相关人员可以透过建立策略联盟并专注于拓展新兴市场来抓住这些机会。然而，市场面临着阻碍成长的挑战，例如高昂的初始生产成本和严格的监管要求。此外，竞争激烈，需要不断创新。儘管存在这些挑战，多特异性抗体药物复合体的开发创新提供了利润丰厚的机会。将研究扩展到双特异性抗体和奈米抗体等领域可以提供重要的成长途径。考虑到市场竞争格局，重点是开发强大的抗体发现平台，竞争非常激烈。市场的本质是研究集中和动态的，不断的进步既带来了机会，也带来了挑战。因此，鼓励公司投资先进的研究技术并保持敏捷的运营，以适应新的市场需求并利用尖端科学进步实现永续成长。

主要市场统计
基准年[2023] 75586万美元
预计年份 [2024] 87188万美元
预测年份 [2030] 21.499 亿美元
复合年增长率（%） 16.10%

市场动态：揭示快速发展的自订抗体市场的关键市场洞察

自订抗体市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性感染疾病全球流行
    • 扩大客自订抗体在研究、诊断和治疗的应用
    • 更多采用抗体工程和个人化治疗的先进技术
  • 市场限制因素
    • 开发客自订抗体需要花费大量的时间和精力。
  • 市场机会
    • 政府和私营部门对生命科学和临床研究的策略性投资
    • 抗体疗法的增加和药物管道的扩展
  • 市场挑战
    • 替代抗体的存在

波特五自订策略工具引领客製化抗体市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解自订抗体市场的外部影响

外部宏观环境因素在塑造客自订抗体市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解自订抗体市场的竞争格局

客自订抗体市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位自订抗体市场供应商绩效评估

FPNV定位矩阵是评估自订抗体市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製自订抗体市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，自订抗体市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性感染疾病率增加
      • 扩展自订抗体在研究、诊断和治疗领域的应用
      • 更多采用抗体工程和个人化治疗的先进技术
    • 抑制因素
      • 开发客自订抗体需要大量时间和精力。
    • 机会
      • 政府和私营部门对生命科学和临床研究进行策略性投资
      • 抗体疗法的增加和药物管道的扩展
    • 任务
      • 替代抗体的存在
  • 市场区隔分析
    • 类型：对单株抗体解决严重的新兴需求
    • 最终用户：製药和生技公司增加对药物开发和诊断的投资
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章客自订抗体市场：依类型

  • 单株抗体
  • 多株抗体
  • 重组抗体

第七章客自订抗体市场：依服务分类

  • 抗体开发
  • 抗体片段化和标记
  • 抗体生产和精製

第 8 章客自订抗体市场：依来源分类

  • 老鼠
  • 兔子

第 9 章自订抗体市场研究（按领域）

  • 心血管疾病
  • 免疫学
  • 感染疾病
  • 神经生物学
  • 肿瘤学
  • 干细胞

第 10 章客自订抗体市场：依最终用户分类

  • 学术研究所
  • 合约调查机构
  • 医院/诊所
  • 製药和生物技术公司

第十一章客自订抗体市场：依应用分类

  • 调查
  • 治疗药物

第十二章美洲客自订抗体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区自订抗体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东、非洲客自订抗体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 丹纳赫将以 57 亿美元收购抗体供应商 Abcam
    • 默克斥资 108 亿美元收购单株抗体
    • Celltrion 和 Genuve 合作开发新的治疗抗体
  • 战略分析和建议

公司名单

  • Abbiotec, Inc.
  • Abcam PLC
  • ABclonal, Inc.
  • Abgenex Pvt. Ltd.
  • Abnova Corporation
  • Acrobiosystems Inc.
  • Agilent Technologies, Inc.
  • Alta Bioscience Limited
  • Bio Basic Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioChain Incorporated
  • Bioklone Biotech Private Limited
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biosynth Ltd.
  • Boster Biological Technology
  • BTL Biotechno Labs Private Limited
  • Capralogics, Inc.
  • Cell Signaling Technology, Inc.
  • CiteAb Limited
  • Creative Biolabs
  • Creative Diagnostics
  • CSBio（Shanghai）Ltd.
  • Cusabio Technology LLC
  • Davids Biotechnologie GmbH
  • Elabscience
  • evitria AG by Atlas Antibiodies
  • GenScript Biotech Corporation
  • Imgenex India Pvt. Ltd.
  • Innovagen AB
  • Inotiv, Inc.
  • Kaneka Eurogentec SA
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Metabion International AG
  • MyBiosource, Inc.
  • OriGene Technologies, Inc.
  • Oy Medix Biochemica AB
  • Pacific Immunology
  • PhosphoSolutions
  • ProMab Biotechnologies, Inc.
  • ProSci Incorporated
  • ProteoGenix SA
  • RayBiotech Life, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • The Antibody Company
  • Thermo Fisher Scientific, Inc.
  • YenZym Antibodies, LLC
Product Code: MRR-46132FF79A8E

The Custom Antibody Market was valued at USD 755.86 million in 2023, expected to reach USD 871.88 million in 2024, and is projected to grow at a CAGR of 16.10%, to USD 2,149.90 million by 2030.

The custom antibody market is defined by the development and sale of antibodies tailored to specific antigens or epitopes for a diverse range of applications in research, diagnostics, and therapeutics. The necessity for custom antibodies stems from their ability to provide specificity and sensitivity in detecting target proteins, which is crucial in fields such as immunology, oncology, and neurobiology. Applications include use in ELISA, western blotting, immunohistochemistry, and flow cytometry, serving end-use sectors like pharmaceutical companies, academic research institutions, and diagnostic labs. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing investment in research and development, and the growing number of collaborations between biotech firms and research institutes. The latest opportunities in this market include the advancement of antibody discovery technologies such as phage display and next-generation sequencing which enhance the ability to develop high-affinity antibodies swiftly. Market players are encouraged to form strategic alliances and focus on expansion into emerging markets to seize these opportunities. However, the market faces challenges including high initial production costs and stringent regulatory requirements which can hinder growth. Additionally, there is intense competition which necessitates continuous innovation. Despite these challenges, innovation in the development of multi-specific and antibody-drug conjugates presents lucrative opportunities. Expanding research into areas such as bispecific antibodies and nanobodies can offer significant growth avenues. Insight into the market indicates a highly competitive landscape with a strong focus on developing robust antibody discovery platforms. The market's nature is research-intensive and dynamic, with continuous advancements offering both opportunities and challenges. As such, businesses are recommended to invest in advanced research technologies and maintain agile operations to adapt to new market demands and leverage cutting-edge scientific advancements for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 755.86 million
Estimated Year [2024] USD 871.88 million
Forecast Year [2030] USD 2,149.90 million
CAGR (%) 16.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Custom Antibody Market

The Custom Antibody Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic infectious disease worldwide
    • Expanding applications of custom antibody across research, diagnostics, and therapeutics
    • Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
  • Market Restraints
    • Extensive and time consuming to develop custom antibodies
  • Market Opportunities
    • Governments and private sector strategically investments in life science and clinical research
    • Increase in therapeutics of antibodies and expansion of drug pipeline
  • Market Challenges
    • Presence of alternative antibodies

Porter's Five Forces: A Strategic Tool for Navigating the Custom Antibody Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Custom Antibody Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Custom Antibody Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Custom Antibody Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Custom Antibody Market

A detailed market share analysis in the Custom Antibody Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Custom Antibody Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Custom Antibody Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Custom Antibody Market

A strategic analysis of the Custom Antibody Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG by Atlas Antibiodies, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.

Market Segmentation & Coverage

This research report categorizes the Custom Antibody Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies.
  • Based on Service, market is studied across Antibody Development, Antibody Fragmentation & Labeling, and Antibody Production & Purification.
  • Based on Source, market is studied across Mice and Rabbit.
  • Based on Research Area, market is studied across Cardiovascular Diseases, Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem cells.
  • Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on Application, market is studied across Research and Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic infectious disease worldwide
      • 5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
      • 5.1.1.3. Rising adoption of advanced technologies in antibody engineering and personalized therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Extensive and time consuming to develop custom antibodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Governments and private sector strategically investments in life science and clinical research
      • 5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative antibodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Emerging need for monoclonal antibodies to tackle severe disease states
    • 5.2.2. End Users: Expanding investments by the pharmaceutical & biotechnology companies in drug development and diagnostics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Custom Antibody Market, by Type

  • 6.1. Introduction
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Custom Antibody Market, by Service

  • 7.1. Introduction
  • 7.2. Antibody Development
  • 7.3. Antibody Fragmentation & Labeling
  • 7.4. Antibody Production & Purification

8. Custom Antibody Market, by Source

  • 8.1. Introduction
  • 8.2. Mice
  • 8.3. Rabbit

9. Custom Antibody Market, by Research Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Immunology
  • 9.4. Infectious Diseases
  • 9.5. Neurobiology
  • 9.6. Oncology
  • 9.7. Stem cells

10. Custom Antibody Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Custom Antibody Market, by Application

  • 11.1. Introduction
  • 11.2. Research
  • 11.3. Therapeutics

12. Americas Custom Antibody Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Custom Antibody Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Custom Antibody Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Danaher to Buy Antibody Supplier Abcam for USD 5.7 Billion
    • 15.3.2. Merck to Develop mAb Through USD 10.8 Billion Acquisition
    • 15.3.3. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbiotec, Inc.
  • 2. Abcam PLC
  • 3. ABclonal, Inc.
  • 4. Abgenex Pvt. Ltd.
  • 5. Abnova Corporation
  • 6. Acrobiosystems Inc.
  • 7. Agilent Technologies, Inc.
  • 8. Alta Bioscience Limited
  • 9. Bio Basic Inc.
  • 10. Bio-Rad Laboratories, Inc.
  • 11. Bio-Techne Corporation
  • 12. BioChain Incorporated
  • 13. Bioklone Biotech Private Limited
  • 14. BioLegend, Inc. by PerkinElmer, Inc.
  • 15. Biosynth Ltd.
  • 16. Boster Biological Technology
  • 17. BTL Biotechno Labs Private Limited
  • 18. Capralogics, Inc.
  • 19. Cell Signaling Technology, Inc.
  • 20. CiteAb Limited
  • 21. Creative Biolabs
  • 22. Creative Diagnostics
  • 23. CSBio (Shanghai) Ltd.
  • 24. Cusabio Technology LLC
  • 25. Davids Biotechnologie GmbH
  • 26. Elabscience
  • 27. evitria AG by Atlas Antibiodies
  • 28. GenScript Biotech Corporation
  • 29. Imgenex India Pvt. Ltd.
  • 30. Innovagen AB
  • 31. Inotiv, Inc.
  • 32. Kaneka Eurogentec S.A.
  • 33. Laboratory Corporation of America Holdings
  • 34. Merck KGaA
  • 35. Metabion International AG
  • 36. MyBiosource, Inc.
  • 37. OriGene Technologies, Inc.
  • 38. Oy Medix Biochemica AB
  • 39. Pacific Immunology
  • 40. PhosphoSolutions
  • 41. ProMab Biotechnologies, Inc.
  • 42. ProSci Incorporated
  • 43. ProteoGenix SA
  • 44. RayBiotech Life, Inc.
  • 45. Rockland Immunochemicals, Inc.
  • 46. Sino Biological, Inc.
  • 47. The Antibody Company
  • 48. Thermo Fisher Scientific, Inc.
  • 49. YenZym Antibodies, LLC

LIST OF FIGURES

  • FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
  • FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CUSTOM ANTIBODY MARKET DYNAMICS
  • TABLE 7. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023